Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Boutron

Showing results (51-60 of 290) with videos related to

Pageof 29
Sort By:
BMJ Open|August 27, 2013
Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional studySally Hopewell, Isabelle Boutron, Douglas G Altman, et al.
Journal of Clinical Epidemiology|April 14, 2024
Psychometric properties and domains covered by patient-reported outcome measures used in trials assessing interventions for chronic painFarzaneh Alebouyeh, Isabelle Boutron, Philippe Ravaud, et al.
Journal of Clinical Epidemiology|April 20, 2015
Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferencesSally Hopewell, Isabelle Boutron, Douglas G Altman, et al.
JAMA|May 27, 2010
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomesIsabelle Boutron, Susan Dutton, Philippe Ravaud, et al.
Journal of Clinical Epidemiology|July 23, 2019
A systematic review finds that spin or interpretation bias is abundant in evaluations of ovarian cancer biomarkersMona Ghannad, Maria Olsen, Isabelle Boutron, et al.
BMC Medicine|May 1, 2014
Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trialCéline Buffel du Vaure, Isabelle Boutron, Elodie Perrodeau, et al.
Annals of Surgery|October 25, 2006
The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic reviewIsabelle Jacquier, Isabelle Boutron, David Moher, et al.
Trials|March 2, 2010
Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic reviewNizar Ahmad, Isabelle Boutron, Agnès Dechartres, et al.
BMC Medical Research Methodology|January 11, 2024
Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trialsMauricia Davidson, Theodoros Evrenoglou, Carolina Graña, et al.
Journal of the Royal Society of Medicine|November 22, 2023
The differences and overlaps between 'explanatory' and 'pragmatic' controlled trials: a historical perspectivePaul Glasziou, Robert Matthews, Isabelle Boutron, et al.
Pageof 29

Showing results (51-60 of 290) with videos related to

Sort By:
Pageof 29
BMJ Open|August 27, 2013
Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional studySally Hopewell, Isabelle Boutron, Douglas G Altman, et al.
Journal of Clinical Epidemiology|April 14, 2024
Psychometric properties and domains covered by patient-reported outcome measures used in trials assessing interventions for chronic painFarzaneh Alebouyeh, Isabelle Boutron, Philippe Ravaud, et al.
Journal of Clinical Epidemiology|April 20, 2015
Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferencesSally Hopewell, Isabelle Boutron, Douglas G Altman, et al.
JAMA|May 27, 2010
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomesIsabelle Boutron, Susan Dutton, Philippe Ravaud, et al.
Journal of Clinical Epidemiology|July 23, 2019
A systematic review finds that spin or interpretation bias is abundant in evaluations of ovarian cancer biomarkersMona Ghannad, Maria Olsen, Isabelle Boutron, et al.
BMC Medicine|May 1, 2014
Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trialCéline Buffel du Vaure, Isabelle Boutron, Elodie Perrodeau, et al.
Annals of Surgery|October 25, 2006
The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic reviewIsabelle Jacquier, Isabelle Boutron, David Moher, et al.
Trials|March 2, 2010
Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic reviewNizar Ahmad, Isabelle Boutron, Agnès Dechartres, et al.
BMC Medical Research Methodology|January 11, 2024
Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trialsMauricia Davidson, Theodoros Evrenoglou, Carolina Graña, et al.
Journal of the Royal Society of Medicine|November 22, 2023
The differences and overlaps between 'explanatory' and 'pragmatic' controlled trials: a historical perspectivePaul Glasziou, Robert Matthews, Isabelle Boutron, et al.
Pageof 29